English
简体中文
Total: £ 56.28
Published Date: 2025-06-18 | Pages: 111 | Tables: 116 | Pharma & Healthcare
In 2024, the global market size of Age Related Macular Degeneration Drug was estimated to be worth US$ 8657 million and is forecast to reach approximately US$ 12860 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration Drug.
The Age Related Macular Degeneration Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Age Related Macular Degeneration Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age Related Macular Degeneration Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Segment by Type
Lucentis
Eylea
Avastin
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Age Related Macular Degeneration Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Age Related Macular Degeneration Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Age Related Macular Degeneration Drug sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Age Related Macular Degeneration Drug Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Age Related Macular Degeneration Drug Market Size Estimates and Forecasts
2.1.1 Global Age Related Macular Degeneration Drug Revenue 2020-2031
2.1.2 Global Age Related Macular Degeneration Drug Sales 2020-2031
2.2 Age Related Macular Degeneration Drug Market Size by Region: 2024 Versus 2031
2.3 Age Related Macular Degeneration Drug Sales by Region (2020-2031)
2.3.1 Global Age Related Macular Degeneration Drug Sales by Region: 2020-2025
2.3.2 Global Age Related Macular Degeneration Drug Sales Forecast by Region (2026-2031)
2.3.3 Global Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2031)
2.4 Age Related Macular Degeneration Drug Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Age Related Macular Degeneration Drug Revenue by Region: 2020-2025
2.4.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2026-2031)
2.4.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Age Related Macular Degeneration Drug Sales by Type (2020-2031)
3.1.1.1 Global Age Related Macular Degeneration Drug Sales Volume by Type (2020-2031)
3.1.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2031)
3.1.2 Global Age Related Macular Degeneration Drug Revenue by Type (2020-2031)
3.1.2.1 Global Age Related Macular Degeneration Drug Revenue by Type (2020-2031)
3.1.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2020-2031)
3.1.3 Age Related Macular Degeneration Drug Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Age Related Macular Degeneration Drug Sales by Application (2020-2031)
3.2.1.1 Global Age Related Macular Degeneration Drug Sales Volume by Application (2020-2031)
3.2.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2031)
3.2.2 Global Age Related Macular Degeneration Drug Revenue by Application (2020-2031)
3.2.2.1 Global Age Related Macular Degeneration Drug Revenue by Application (2020-2031)
3.2.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2020-2031)
3.2.3 Age Related Macular Degeneration Drug Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Lucentis of Age Related Macular Degeneration Drug Revenue Market Share by Application
3.3.2 Eylea of Age Related Macular Degeneration Drug Revenue Market Share by Application
3.3.3 Avastin of Age Related Macular Degeneration Drug Revenue Market Share by Application
3.3.4 Others of Age Related Macular Degeneration Drug Revenue Market Share by Application
4 Global Age Related Macular Degeneration Drug by Manufacturers
4.1 Global Top Age Related Macular Degeneration Drug Manufacturers by Sales (2020-2025)
4.1.1 Global Age Related Macular Degeneration Drug Sales by Manufacturer (2020-2025)
4.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Age Related Macular Degeneration Drug Manufacturers by Revenue (2020-2025)
4.2.1 Global Age Related Macular Degeneration Drug Revenue by Manufacturer (2020-2025)
4.2.2 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturer (2020-2025)
4.3 Global Age Related Macular Degeneration Drug Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Age Related Macular Degeneration Drug Manufacturers Covered: Ranking by Revenue
4.4.2 Global Age Related Macular Degeneration Drug Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Age Related Macular Degeneration Drug Manufacturing Base Distribution, Product Type
4.5.1 Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market
4.5.3 Manufacturers Age Related Macular Degeneration Drug Product Type and Application
4.5.4 Lucentis Market Sales of Age Related Macular Degeneration Drug by Manufacturer
4.5.5 Eylea Market Sales of Age Related Macular Degeneration Drug by Manufacturer
4.5.6 Avastin Market Sales of Age Related Macular Degeneration Drug by Manufacturer
4.5.7 Others Market Sales of Age Related Macular Degeneration Drug by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Regeneron Pharmaceuticals
5.1.1 Regeneron Pharmaceuticals Company Information
5.1.2 Regeneron Pharmaceuticals Description, Business Overview
5.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
5.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales by Product in 2024
5.1.6 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales by Application in 2024
5.1.7 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales by Geographic Area in 2024
5.1.8 Regeneron Pharmaceuticals Recent Developments
5.2 Bayer HealthCare
5.2.1 Bayer HealthCare Company Information
5.2.2 Bayer HealthCare Description, Business Overview
5.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
5.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Bayer HealthCare Age Related Macular Degeneration Drug Sales by Product in 2024
5.2.6 Bayer HealthCare Age Related Macular Degeneration Drug Sales by Application in 2024
5.2.7 Bayer HealthCare Age Related Macular Degeneration Drug Sales by Geographic Area in 2024
5.2.8 Bayer HealthCare Recent Developments
5.3 Novartis
5.3.1 Novartis Company Information
5.3.2 Novartis Description, Business Overview
5.3.3 Novartis Age Related Macular Degeneration Drug Products Offered
5.3.4 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Novartis Age Related Macular Degeneration Drug Sales by Product in 2024
5.3.6 Novartis Age Related Macular Degeneration Drug Sales by Application in 2024
5.3.7 Novartis Age Related Macular Degeneration Drug Sales by Geographic Area in 2024
5.3.8 Novartis Recent Developments
5.4 Roche
5.4.1 Roche Company Information
5.4.2 Roche Description, Business Overview
5.4.3 Roche Age Related Macular Degeneration Drug Products Offered
5.4.4 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Roche Age Related Macular Degeneration Drug Sales by Product in 2024
5.4.6 Roche Age Related Macular Degeneration Drug Sales by Application in 2024
5.4.7 Roche Age Related Macular Degeneration Drug Sales by Geographic Area in 2024
5.4.8 Roche Recent Developments
5.5 Kanghong Pharma
5.5.1 Kanghong Pharma Company Information
5.5.2 Kanghong Pharma Description, Business Overview
5.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
5.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Kanghong Pharma Age Related Macular Degeneration Drug Sales by Product in 2024
5.5.6 Kanghong Pharma Age Related Macular Degeneration Drug Sales by Application in 2024
5.5.7 Kanghong Pharma Age Related Macular Degeneration Drug Sales by Geographic Area in 2024
5.5.8 Kanghong Pharma Recent Developments
6 North America
6.1 North America Age Related Macular Degeneration Drug Market Size YoY Growth 2020-2031
6.2 North America Age Related Macular Degeneration Drug Market Facts & Figures by Country
6.2.1 North America Age Related Macular Degeneration Drug Sales by Country (2020-2031)
6.2.2 North America Age Related Macular Degeneration Drug Revenue by Country (2020-2031)
6.3 North America Age Related Macular Degeneration Drug Sales by Type (2020-2025)
6.4 North America Age Related Macular Degeneration Drug Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Age Related Macular Degeneration Drug Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Age Related Macular Degeneration Drug Market Facts & Figures by Region
7.2.1 Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2020-2031)
7.2.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue by Region (2020-2031)
7.3 Asia-Pacific Age Related Macular Degeneration Drug Sales by Type (2020-2025)
7.4 Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2020-2025)
8 Europe
8.1 Europe Age Related Macular Degeneration Drug Market Size YoY Growth 2020-2031
8.2 Europe Age Related Macular Degeneration Drug Market Facts & Figures by Country
8.2.1 Europe Age Related Macular Degeneration Drug Sales by Country (2020-2031)
8.2.2 Europe Age Related Macular Degeneration Drug Revenue by Country (2020-2031)
8.3 Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025)
8.4 Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Age Related Macular Degeneration Drug Market Size YoY Growth 2020-2031
9.2 Latin America Age Related Macular Degeneration Drug Market Facts & Figures by Country
9.2.1 Latin America Age Related Macular Degeneration Drug Sales by Country (2020-2031)
9.2.2 Latin America Age Related Macular Degeneration Drug Revenue by Country (2020-2031)
9.3 Latin America Age Related Macular Degeneration Drug Sales by Type (2020-2025)
9.4 Latin America Age Related Macular Degeneration Drug Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Age Related Macular Degeneration Drug Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Age Related Macular Degeneration Drug Market Facts & Figures by Country
10.2.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2020-2031)
10.2.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2020-2031)
10.3 Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2020-2025)
10.4 Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Age Related Macular Degeneration Drug Supply Chain Analysis
11.2 Age Related Macular Degeneration Drug Key Raw Materials and Upstream Suppliers
11.3 Age Related Macular Degeneration Drug Clients Analysis
11.4 Age Related Macular Degeneration Drug Sales Channel and Sales Model Analysis
11.4.1 Age Related Macular Degeneration Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Age Related Macular Degeneration Drug Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Age Related Macular Degeneration Drug Distributors
12 Age Related Macular Degeneration Drug Market Dynamics
12.1 Age Related Macular Degeneration Drug Industry Trends
12.2 Age Related Macular Degeneration Drug Market Drivers
12.3 Age Related Macular Degeneration Drug Market Challenges
12.4 Age Related Macular Degeneration Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Age Related Macular Degeneration Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Age Related Macular Degeneration Drug Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Age Related Macular Degeneration Drug Sales by Region (2020-2025) & (K Units)
Table 5. Global Age Related Macular Degeneration Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Age Related Macular Degeneration Drug Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Age Related Macular Degeneration Drug Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Age Related Macular Degeneration Drug Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Age Related Macular Degeneration Drug Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Age Related Macular Degeneration Drug Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Age Related Macular Degeneration Drug Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Age Related Macular Degeneration Drug Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Age Related Macular Degeneration Drug Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Age Related Macular Degeneration Drug Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Age Related Macular Degeneration Drug Sales Share by Manufacturer (2020-2025)
Table 18. Age Related Macular Degeneration Drug Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Age Related Macular Degeneration Drug Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Age Related Macular Degeneration Drug Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Age Related Macular Degeneration Drug Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Age Related Macular Degeneration Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2024)
Table 24. Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market
Table 26. Manufacturers Age Related Macular Degeneration Drug Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Regeneron Pharmaceuticals Company Information
Table 29. Regeneron Pharmaceuticals Description and Business Overview
Table 30. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 31. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Regeneron Pharmaceuticals Sales Proportion of Age Related Macular Degeneration Drug by Product in 2024
Table 33. Regeneron Pharmaceuticals Sales Proportion of Age Related Macular Degeneration Drug by Application in 2024
Table 34. Regeneron Pharmaceuticals Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2024
Table 35. Regeneron Pharmaceuticals Recent Developments
Table 36. Bayer HealthCare Company Information
Table 37. Bayer HealthCare Description and Business Overview
Table 38. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 39. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Bayer HealthCare Sales Proportion of Age Related Macular Degeneration Drug by Product in 2024
Table 41. Bayer HealthCare Sales Proportion of Age Related Macular Degeneration Drug by Application in 2024
Table 42. Bayer HealthCare Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2024
Table 43. Bayer HealthCare Recent Developments
Table 44. Novartis Company Information
Table 45. Novartis Description and Business Overview
Table 46. Novartis Age Related Macular Degeneration Drug Product
Table 47. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Novartis Sales Proportion of Age Related Macular Degeneration Drug by Product in 2024
Table 49. Novartis Sales Proportion of Age Related Macular Degeneration Drug by Application in 2024
Table 50. Novartis Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2024
Table 51. Novartis Recent Developments
Table 52. Roche Company Information
Table 53. Roche Description and Business Overview
Table 54. Roche Age Related Macular Degeneration Drug Product
Table 55. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Roche Sales Proportion of Age Related Macular Degeneration Drug by Product in 2024
Table 57. Roche Sales Proportion of Age Related Macular Degeneration Drug by Application in 2024
Table 58. Roche Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2024
Table 59. Roche Recent Developments
Table 60. Kanghong Pharma Company Information
Table 61. Kanghong Pharma Description and Business Overview
Table 62. Kanghong Pharma Age Related Macular Degeneration Drug Product
Table 63. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Kanghong Pharma Sales Proportion of Age Related Macular Degeneration Drug by Product in 2024
Table 65. Kanghong Pharma Sales Proportion of Age Related Macular Degeneration Drug by Application in 2024
Table 66. Kanghong Pharma Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2024
Table 67. Kanghong Pharma Recent Developments
Table 68. North America Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 69. North America Age Related Macular Degeneration Drug Sales by Country (2026-2031) & (K Units)
Table 70. North America Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & (US$ Million)
Table 71. North America Age Related Macular Degeneration Drug Revenue by Country (2026-2031) & (US$ Million)
Table 72. North America Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 73. North America Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 74. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2020-2025) & (K Units)
Table 75. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2026-2031) & (K Units)
Table 76. Asia-Pacific Age Related Macular Degeneration Drug Revenue by Region (2020-2025) & (US$ Million)
Table 77. Asia-Pacific Age Related Macular Degeneration Drug Revenue by Region (2026-2031) & (US$ Million)
Table 78. Asia-Pacific Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 79. Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 80. Europe Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 81. Europe Age Related Macular Degeneration Drug Sales by Country (2026-2031) & (K Units)
Table 82. Europe Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & (US$ Million)
Table 83. Europe Age Related Macular Degeneration Drug Revenue by Country (2026-2031) & (US$ Million)
Table 84. Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 85. Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 86. Latin America Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 87. Latin America Age Related Macular Degeneration Drug Sales by Country (2026-2031) & (K Units)
Table 88. Latin America Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & (US$ Million)
Table 89. Latin America Age Related Macular Degeneration Drug Revenue by Country (2026-2031) & (US$ Million)
Table 90. Latin America Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 91. Latin America Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 92. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 93. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2026-2031) & (K Units)
Table 94. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & (US$ Million)
Table 95. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2026-2031) & (US$ Million)
Table 96. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 97. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 98. Age Related Macular Degeneration Drug Key Raw Materials, Industry Status and Trend
Table 99. Age Related Macular Degeneration Drug Key Raw Materials and Upstream Suppliers
Table 100. Age Related Macular Degeneration Drug Clients Status and Trend
Table 101. Age Related Macular Degeneration Drug Typical Clients
Table 102. Age Related Macular Degeneration Drug Distributors
Table 103. Age Related Macular Degeneration Drug Market Trends
Table 104. Age Related Macular Degeneration Drug Market Drivers
Table 105. Age Related Macular Degeneration Drug Market Challenges
Table 106. Age Related Macular Degeneration Drug Market Restraints
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Lucentis Product Picture
Figure 5. Eylea Product Picture
Figure 6. Avastin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Age Related Macular Degeneration Drug Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Age Related Macular Degeneration Drug Sales Market Share by Application in 2024 & 2031
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Age Related Macular Degeneration Drug Report Years Considered
Figure 14. Global Age Related Macular Degeneration Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Age Related Macular Degeneration Drug Market Size 2020-2031 (US$ Million)
Figure 16. Global Age Related Macular Degeneration Drug Sales 2020-2031 (K Units)
Figure 17. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2020-2031)
Figure 18. Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2031)
Figure 19. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2020-2031)
Figure 20. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Age Related Macular Degeneration Drug Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 22. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2020-2031)
Figure 23. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Application (2020-2031)
Figure 24. Age Related Macular Degeneration Drug Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 25. Lucentis of Age Related Macular Degeneration Drug Revenue Market Share by Application, 2024 VS 2031
Figure 26. Eylea of Age Related Macular Degeneration Drug Revenue Market Share by Application, 2024 VS 2031
Figure 27. Avastin of Age Related Macular Degeneration Drug Revenue Market Share by Application, 2024 VS 2031
Figure 28. Others of Age Related Macular Degeneration Drug Revenue Market Share by Application, 2024 VS 2031
Figure 29. Global Age Related Macular Degeneration Drug Sales Share by Manufacturer in 2024
Figure 30. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Lucentis Market Sales Proportion by Manufacturer in 2024
Figure 32. Eylea Market Sales Proportion by Manufacturer in 2024
Figure 33. Avastin Market Sales Proportion by Manufacturer in 2024
Figure 34. Others Market Sales Proportion by Manufacturer in 2024
Figure 35. North America Age Related Macular Degeneration Drug Revenue 2020-2031 (US$ Million)
Figure 36. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 37. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 38. Asia-Pacific Age Related Macular Degeneration Drug Revenue 2020-2031 (US$ Million)
Figure 39. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2031)
Figure 40. Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 42. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 43. Europe Age Related Macular Degeneration Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Europe Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2031)
Figure 45. Europe Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2031)
Figure 46. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 47. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 48. Latin America Age Related Macular Degeneration Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 49. Latin America Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2031)
Figure 50. Latin America Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Figure 51. Latin America Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 52. Latin America Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 53. Middle East and Africa Age Related Macular Degeneration Drug Revenue Growth Rate 2020-2031 (US$ Million)
Figure 54. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 57. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 58. Age Related Macular Degeneration Drug Supply Chain (Upstream and Downstream Market)
Figure 59. Global Production Market Share of Age Related Macular Degeneration Drug Raw Materials by Region in 2024
Figure 60. Age Related Macular Degeneration Drug Distribution Channels
Figure 61. Global Age Related Macular Degeneration Drug Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 62. Global Age Related Macular Degeneration Drug Percentage 2020-2031: Online Sales VS Offline Sales
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
